P/E Ratio
Updated 200h ago
Sector Performance
79th percentileWAT
40.8x
Sector Median
24.7x
Sector Avg
36.0x
Deep Analysis
The current P/E (price-to-earnings) ratio of 40.8x means investors are paying $40.80 for every $1 of the company’s annual earnings — a measure of how expensive the stock is relative to its profitability.
Compared to sector peers, this ratio is well above the sector median of 24.1x, placing the stock in the 79th percentile, indicating it trades at a premium versus most competitors. No trend data is available: the year-over-year change, quarter-over-quarter change, and the trend direction over the last eight quarters are all marked as N/A. Without a historical trend, it is impossible to gauge whether the P/E is rising, falling, or stable, adding uncertainty to the valuation. The combination of a high absolute P/E (40.8x) and no trend data suggests elevated valuation risk — investors are paying a premium but lack information on how that premium has evolved. This metric supports the overall NEUTRAL verdict: the high P/E points to a potentially overvalued stock, but the absence of trend data prevents a stronger bearish or bullish stance.
Frequently Asked Questions
What does the P/E Ratio tell investors about WAT?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are WAT's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: VICI (9.1x), OMF (9.0x), JACK (8.5x), GIS (8.4x), FIS (8.4x).
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master WAT's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full WAT research report →WAT
40.8x
Sector Median
24.7x
Sector Avg
36.0x
How WAT's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.